Simonian Nancy A Insider Trades

Insider Trading History

Track insider trading activity for Simonian Nancy A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $0.8 4,000 shares
Last Trade
Dec 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$10k 37,070 shares
$0.27
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $8.21 41,070 shares
Last Trade
Nov 25, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$36.4k 134,713 shares
$0.27
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $0 0 shares
Last Trade
Oct 31, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 40,125 shares
$2.52
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $35.2 175,783 shares
Last Trade
Oct 31, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 40,125 shares
$2.52
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $27.1 135,658 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8k 6,000 shares
$5.30
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $26.3 131,658 shares
Last Trade
Apr 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$71.9k 14,052 shares
$5.12
$0.00
Seagen
Seagen SGEN
Director
Holding Value $0 0 shares
Last Trade
Dec 14, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$18.5M 80,763 shares
$228.74
$228.74
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $0 0 shares
Last Trade
Dec 01, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$300k 112,798 shares
$2.66
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $20 100,144 shares
Last Trade
Nov 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$29.8k 13,401 shares
$2.22
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $8.03 40,125 shares
Last Trade
Oct 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$99.9k 40,125 shares
$2.49
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $22.7 113,545 shares
Last Trade
Oct 31, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$99.9k 40,125 shares
$2.49
$0.00
Seagen
Seagen SGEN
Director
Holding Value $14.8M 64,797 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 2,044 shares
$195.70
$228.74
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $14.7 73,420 shares
Last Trade
Apr 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.78k 1,852 shares
$2.58
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $15.1 75,272 shares
Last Trade
Mar 31, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16k 6,000 shares
$2.67
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $3.6 18,000 shares
Last Trade
Mar 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16k 6,000 shares
$2.67
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $23.7 118,700 shares
Last Trade
Feb 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$477k 118,700 shares
$4.02
$0.00
Seagen
Seagen SGEN
Director
Holding Value $0 0 shares
Last Trade
Dec 12, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.15M 8,750 shares
$131.84
$228.74
Seagen
Seagen SGEN
Director
Holding Value $14.4M 62,753 shares
Last Trade
Dec 12, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.15M 8,750 shares
$131.84
$228.74
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
President & CEO
Holding Value $23 115,000 shares
Last Trade
Oct 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 195,250 shares
$6.73
$0.00
Seagen
Seagen SGEN
Director
Holding Value $841k 3,676 shares
Last Trade
May 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$499k 3,676 shares
$135.63
$228.74

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up